|
1
|
Stevinson C and Ernst E: Valerian for
insomnia: a systematic review of randomized clinical trials. Sleep
Med. 1:91–99. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Circosta C, De Pasquale R, Samperi S, Pino
A and Occhiuto F: Biological and analytical characterization of two
extracts from Valeriana officinalis. J Ethnopharmacol. 112:361–367.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim JS, Ahn JD and Cho SI: Effects of
Valerianae Radix et Rhizoma extract on psychological stress in
mice. Pharmacogn Mag. 11:381–388. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Barton DL, Atherton PJ, Bauer BA, Moore DF
Jr, Mattar BI, Lavasseur BI, Rowland KM Jr, Zon RT, Lelindqwister
NA, Nagargoje GG, et al: The use of Valeriana officinalis
(Valerian) in improving sleep in patients who are undergoing
treatment for cancer: a phase III randomized, placebo-controlled,
double-blind study (NCCTG Trial, N01C5). J Support Oncol. 9:24–31.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rezvani ME, Roohbakhsh A, Allahtavakoli M
and Shamsizadeh A: Anticonvulsant effect of aqueous extract of
Valeriana officinalis in amygdala-kindled rats: possible
involvement of adenosine. J Ethnopharmacol. 127:313–318. 2010.
View Article : Google Scholar
|
|
6
|
Murphy K, Kubin ZJ, Shepherd JN and
Ettinger RH: Valeriana officinalis root extracts have potent
anxiolytic effects in laboratory rats. Phytomedicine. 17:674–678.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang PC, Ran XH, Chen R, Luo HR, Liu YQ,
Zhou J and Zhao YX: Germacrane-type sesquiterpenoids from the roots
of Valeriana officinalis var. latifolia. J Nat Prod. 73:1563–1567.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Letchamo W, Ward W, Heard B and Heard D:
Essential oil of Valeriana officinalis L. cultivars and their
antimicrobial activity as influenced by harvesting time under
commercial organic cultivation. J Agric Food Chem. 52:3915–3919.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leuschner J, Müller J and Rudmann M:
Characterisation of the central nervous depressant activity of a
commercially available valerian root extract.
Arzneimittelforschung. 43:638–641. 1993.PubMed/NCBI
|
|
10
|
Hadley S and Petry JJ: Valerian. Am Fam
Physician. 67:1755–1758. 2003.PubMed/NCBI
|
|
11
|
Yuan CS, Mehendale S, Xiao Y, Aung HH, Xie
JT and Ang-Lee MK: The gamma-aminobutyric acidergic effects of
valerian and valerenic acid on rat brainstem neuronal activity.
Anesth Analg. 98:353–358. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sudati JH, Fachinetto R, Pereira RP,
Boligon AA, Athayde ML, Soares FA, de Vargas Barbosa NB and Rocha
JB: In vitro antioxidant activity of Valeriana officinalis against
different neurotoxic agents. Neurochem Res. 34:1372–1379. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
de Oliveria DM, Barreto G, De Andrade DVG,
Saraceno E, Aon-Bertolino L, Capani F, Dos Santos El, Bachá R and
Giraldez LD: Cytoprotective effect of Valeriana officinalis extract
on an in vitro experimental model of Parkinson disease. Neurochem
Res. 34:215–220. 2009. View Article : Google Scholar
|
|
14
|
Malva JO, Santos S and Macedo T:
Neuroprotective properties of Valeriana officinalis extracts.
Neurotox Res. 6:131–140. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pereira RP, Fachinetto R, de Souza Prestes
A, Wagner C, Sudati JH, Boligon AA, Athayde ML, Morsch VM and Rocha
JBT: Valeriana officinalis ameliorates vacuous chewing movements
induced by reserpine in rats. J Neural Transm Vienna.
118:1547–1557. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brown AS, van Os J, Driessens C, Hoek HW
and Susser ES: Further evidence of relation between prenatal famine
and major affective disorder. Am J Psychiatry. 157:190–195. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sullivan PF: The genetics of
schizophrenia. PLoS Med. 2:e2122005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huttunen MO and Niskanen P: Prenatal loss
of father and psychiatric disorders. Arch Gen Psychiatry.
35:429–431. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
King M, Nazroo J, Weich S, McKenzie K,
Bhui K, Karlsen S, Stansfeld S, Tyrer P, Blanchard M, Lloyd K, et
al: Psychotic symptoms in the general population of England - a
comparison of ethnic groups (The EMPIRIC study). Soc Psychiatry
Psychiatr Epidemiol. 40:375–381. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
King S, Laplante D and Joober R:
Understanding putative risk factors for schizophrenia:
retrospective and prospective studies. J Psychiatry Neurosci.
30:342–348. 2005.PubMed/NCBI
|
|
21
|
Lim C, Chong SA and Keefe R: Psychosocial
factors in the neurobiology of schizophrenia: a selective review.
Ann Acad Med Singapore. 38:402–406. 2009.PubMed/NCBI
|
|
22
|
Imamura Y, Nakane Y, Ohta Y and Kondo H:
Lifetime prevalence of schizophrenia among individuals prenatally
exposed to atomic bomb radiation in Nagasaki City. Acta Psychiatr
Scand. 100:344–349. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Meyer U and Feldon J: Epidemiology-driven
neurodevelopmental animal models of schizophrenia. Prog Neurobiol.
90:285–326. 2010. View Article : Google Scholar
|
|
24
|
Weinstock M: The long-term behavioural
consequences of prenatal stress. Neurosci Biobehav Rev.
32:1073–1086. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Seckl JR: Prenatal glucocorticoids and
long-term programming. Eur J Endocrinol. 151(Suppl 3): U49–U62.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
de Kloet ER, Sibug RM, Helmerhorst FM and
Schmidt MV: Stress, genes and the mechanism of programming the
brain for later life. Neurosci Biobehav Rev. 29:271–281. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Beydoun H and Saftlas AF: Physical and
mental health outcomes of prenatal maternal stress in human and
animal studies: a review of recent evidence. Paediatr Perinat
Epidemiol. 22:438–466. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee PR, Brady DL, Shapiro RA, Dorsa DM and
Koenig JI: Prenatal stress generates deficits in rat social
behavior: reversal by oxytocin. Brain Res. 1156:152–167. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kinnunen AK, Koenig JI and Bilbe G:
Repeated variable prenatal stress alters pre- and postsynaptic gene
expression in the rat frontal pole. J Neurochem. 86:736–748. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Koenig JI, Elmer GI, Shepard PD, Lee PR,
Mayo C, Joy B, Hercher E and Brady DL: Stress during gestation
produces alterations in adult rat behavior: relevance to
schizophrenia. Soc Neurosci abs. 495:pp. 6http://www.sfn.org/Annual-Meeting/Past-and-Future-Annual-Meetings/Abstract-Archive/Abstract-Archive-Detail?AbsYear=2002&AbsID=7512.
|
|
31
|
Koenig JI, Elmer GI, Shepard PD, Lee PR,
Mayo C, Joy B, Hercher E and Brady DL: Prenatal exposure to a
repeated variable stress paradigm elicits behavioral and
neuroendocrinological changes in the adult offspring: potential
relevance to schizophrenia. Behav Brain Res. 156:251–261. 2005.
View Article : Google Scholar
|
|
32
|
Lemaire V, Koehl M, Le Moal M and Abrous
DN: Prenatal stress produces learning deficits associated with an
inhibition of neurogenesis in the hippocampus. Proc Natl Acad Sci
USA. 97:11032–11037. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Martínez-Téllez RI, Hernández-Torres E,
Gamboa C and Flores G: Prenatal stress alters spine density and
dendritic length of nucleus accumbens and hippocampus neurons in
rat offspring. Synapse. 63:794–804. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Van den Hove DL, Kenis G, Brass A,
Opstelten R, Rutten BP, Bruschettini M, Blanco CE, Lesch KP,
Steinbusch HW and Prickaerts J: Vulnerability versus resilience to
prenatal stress in male and female rats; implications from gene
expression profiles in the hippocampus and frontal cortex. Eur
Neuropsychopharmacol. 23:1226–1246. 2013. View Article : Google Scholar
|
|
35
|
Mairesse J, Vercoutter-Edouart AS,
Marrocco J, Zuena AR, Giovine A, Nicoletti F, Michalski JC, Maccari
S and Morley-Fletcher S: Proteomic characterization in the
hippocampus of prenatally stressed rats. J Proteomics.
75:1764–1770. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee H, Joo J, Nah SS, Kim JW, Kim HK, Kwon
JT, Lee HY, Kim YO and Kim HJ: Changes in Dpysl2 expression are
associated with prenatally stressed rat offspring and
susceptibility to schizophrenia in humans. Int J Mol Med.
35:1574–1586. 2015.PubMed/NCBI
|
|
37
|
Kim YO, Lee HY, Won H, Nah SS, Lee HY, Kim
HK, Kwon JT and Kim HJ: Influence of Panax ginseng on the offspring
of adult rats exposed to prenatal stress. Int J Mol Med.
35:103–109. 2015.
|
|
38
|
Dulawa SC, Holick KA, Gundersen B and Hen
R: Effects of chronic fluoxetine in animal models of anxiety and
depression. Neuropsychopharmacology. 29:1321–1330. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schroeder M, Sultany T and Weller A:
Prenatal stress effects on emotion regulation differ by genotype
and sex in prepubertal rats. Dev Psychobiol. 55:176–192. 2013.
View Article : Google Scholar
|
|
40
|
Becker A, Peters B, Schroeder H, Mann T,
Huether G and Grecksch G: Ketamine-induced changes in rat
behaviour: a possible animal model of schizophrenia. Prog
Neuropsychopharmacol Biol Psychiatry. 27:687–700. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Koenig JI, Elmer GI, Shepard PD, Lee PR,
Mayo C, Joy B, Hercher E and Brady DL: Prenatal exposure to a
repeated variable stress paradigm elicits behavioral and
neuroendocrinological changes in the adult offspring: potential
relevance to schizophrenia. Behav Brain Res. 156:251–261. 2005.
View Article : Google Scholar
|
|
42
|
Chang CH, Hsiao YH, Chen YW, Yu YJ and
Gean PW: Social isolation-induced increase in NMDA receptors in the
hippocampus exacerbates emotional dysregulation in mice.
Hippocampus. 25:474–485. 2015. View Article : Google Scholar
|
|
43
|
Morley-Fletcher S, Darnaudery M, Koehl M,
Casolini P, Van Reeth O and Maccari S: Prenatal stress in rats
predicts immobility behavior in the forced swim test. Effects of a
chronic treatment with tianeptine. Brain Res. 989:246–251. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Joo J, Lee S, Nah SS, Kim YO, Kim DS, Shim
SH, Hwangbo Y, Kim HK, Kwon JT, Kim JW, et al: Lasp1 is
down-regulated in NMDA receptor antagonist-treated mice and
implicated in human schizophrenia susceptibility. J Psychiatr Res.
47:105–112. 2013. View Article : Google Scholar
|
|
45
|
Liu XG, Gao PY, Wang GS, Song SJ, Li LZ,
Li X, Yao XS and Zhang ZX: In vivo antidepressant activity of
sesquiterpenes from the roots of Valeriana fauriei Briq.
Fitoterapia. 83:599–603. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ortiz JG, Nieves-Natal J and Chavez P:
Effects of Valeriana officinalis extracts on [3H]flunitrazepam
binding, synaptosomal [3H] GABA uptake, and hippocampal [3H]GABA
release. Neurochem Res. 24:1373–1378. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Patočka and Jakl J: Biomedically relevant
chemical constituents of Valeriana officinalis. J Appl Biomed.
8:11–18. 2010. View Article : Google Scholar
|
|
48
|
Santos MS, Ferreira F, Cunha AP, Carvalho
AP and Macedo T: An aqueous extract of valerian influences the
transport of GABA in synaptosomes. Planta Med. 60:278–279. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Merz K, Herold S and Lie DC: CREB in adult
neurogenesis - master and partner in the development of adult-born
neurons? Eur J Neurosci. 33:1078–1086. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Charil A, Laplante DP, Vaillancourt C and
King S: Prenatal stress and brain development. Brain Res Brain Res
Rev. 65:56–79. 2010. View Article : Google Scholar
|
|
51
|
Kelley ME, Gilbertson M, Mouton A and van
Kammen DP: Deterioration in premorbid functioning in schizophrenia:
a developmental model of negative symptoms in drug-free patients.
Am J Psychiatry. 149:1543–1548. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Møller P and Husby R: The initial prodrome
in schizophrenia: searching for naturalistic core dimensions of
experience and behavior. Schizophr Bull. 26:217–232. 2000.
View Article : Google Scholar
|
|
53
|
Cornblatt BA: The New York high risk
project to the Hillside recognition and prevention (RAP) program.
Am J Med Genet. 114:956–966. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Geyer MA, Krebs-Thomson K, Braff DL and
Swerdlow NR: Pharmacological studies of prepulse inhibition models
of sensorimotor gating deficits in schizophrenia: a decade in
review. Psychopharmacology (Berl). 156:117–154. 2001. View Article : Google Scholar
|
|
55
|
Swerdlow NR and Geyer MA: Using an animal
model of deficient sensorimotor gating to study the pathophysiology
and new treatments of schizophrenia. Schizophr Bull. 24:285–301.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Braff DL: Information processing and
attention dysfunctions in schizophrenia. Schizophr Bull.
19:233–259. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
de Bruin NM, van Luijtelaar EL, Cools AR
and Ellenbroek BA: Auditory information processing in rat genotypes
with different dopaminergic properties. Psychopharmacology (Berl).
156:352–359. 2001. View Article : Google Scholar
|
|
58
|
Lipska BK and Weinberger DR: To model a
psychiatric disorder in animals: schizophrenia as a reality test.
Neuropsychopharmacology. 23:223–239. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Tueting P, Costa E, Dwivedi Y, Guidotti A,
Impagnatiello F, Manev R and Pesold C: The phenotypic
characteristics of heterozygous reeler mouse. Neuroreport.
10:1329–1334. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Day-Wilson KM, Jones DN, Southam E, Cilia
J and Totterdell S: Medial prefrontal cortex volume loss in rats
with isolation rearing-induced deficits in prepulse inhibition of
acoustic startle. Neuroscience. 141:1113–1121. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Borrell J, Vela JM, Arévalo-Martin A,
Molina-Holgado E and Guaza C: Prenatal immune challenge disrupts
sensorimotor gating in adult rats. Implications for the
etiopathogenesis of schizophrenia. Neuropsychopharmacology.
26:204–215. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Shi L, Fatemi SH, Sidwell RW and Patterson
PH: Maternal influenza infection causes marked behavioral and
pharmacological changes in the offspring. J Neurosci. 23:297–302.
2003.PubMed/NCBI
|
|
63
|
Lehmann J, Stöhr T and Feldon J: Long-term
effects of prenatal stress experiences and postnatal maternal
separation on emotionality and attentional processes. Behav Brain
Res. 107:133–144. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Faraday MM, O'Donoghue VA and Grunberg NE:
Effects of nicotine and stress on startle amplitude and sensory
gating depend on rat strain and sex. Pharmacol Biochem Behav.
62:273–284. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Stöhr T, Schulte Wermeling D, Szuran T,
Pliska V, Domeney A, Welzl H, Weiner I and Feldon J: Differential
effects of prenatal stress in two inbred strains of rats. Pharmacol
Biochem Behav. 59:799–805. 1998. View Article : Google Scholar : PubMed/NCBI
|
